Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
The transaction marks a clear portfolio reshuffle for Indoco
The transaction marks a clear portfolio reshuffle for Indoco
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The initial consideration for the transaction is US$ 12 million
200+ HR leaders and CXOs convened to discuss workforce health, preventive care, and organisational wellbeing as strategic business priorities
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
Subscribe To Our Newsletter & Stay Updated